BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van den Anker J, Allegaert K. Clinical pharmacology in neonates and young infants: the benefit of a population-tailored approach. Expert Rev Clin Pharmacol. 2012;5:5-8. [PMID: 22142152 DOI: 10.1586/ecp.11.65] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Davies JC. Cystic fibrosis: bridging the treatment gap in early childhood. Lancet Respir Med 2013;1:433-4. [PMID: 24429232 DOI: 10.1016/S2213-2600(13)70136-X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Allegaert K. Neonates need tailored drug formulations. World J Clin Pediatr 2013; 2(1): 1-5 [PMID: 25254168 DOI: 10.5409/wjcp.v2.i1.1] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ferrajolo C, Sultana J, Ientile V, Scavone C, Scondotto G, Tari M, Trifirò G, Rossi F, Capuano A. Gender Differences in Outpatient Pediatric Drug Utilization: A Cohort Study From Southern Italy. Front Pharmacol 2019;10:11. [PMID: 30804779 DOI: 10.3389/fphar.2019.00011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
4 Dixon BJ, Reis C, Ho WM, Tang J, Zhang JH. Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci 2015;16:22368-401. [PMID: 26389893 DOI: 10.3390/ijms160922368] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 14.2] [Reference Citation Analysis]
5 Noel GJ, Van Den Anker JN, Lombardi D, Ward R. Improving Drug Formulations for Neonates: Making a Big Difference in Our Smallest Patients. The Journal of Pediatrics 2012;161:947-949.e1. [DOI: 10.1016/j.jpeds.2012.07.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
6 Smits A, Annaert P, Allegaert K. Drug disposition and clinical practice in neonates: Cross talk between developmental physiology and pharmacology. International Journal of Pharmaceutics 2013;452:8-13. [DOI: 10.1016/j.ijpharm.2012.03.035] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
7 Lutsar I, Chazallon C, Carducci FI, Trafojer U, Abdelkader B, de Cabre VM, Esposito S, Giaquinto C, Heath PT, Ilmoja ML, Katragkou A, Lascoux C, Metsvaht T, Mitsiakos G, Netzer E, Pugni L, Roilides E, Saidi Y, Sarafidis K, Sharland M, Usonis V, Aboulker JP; NeoMero Consortium. Current management of late onset neonatal bacterial sepsis in five European countries. Eur J Pediatr 2014;173:997-1004. [PMID: 24522326 DOI: 10.1007/s00431-014-2279-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
8 Wang J, Avant D, Green D, Seo S, Fisher J, Mulberg AE, McCune SK, Burckart GJ. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development. Clin Pharmacol Ther 2015;98:328-35. [PMID: 25975723 DOI: 10.1002/cpt.149] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
9 Jacqz-Aigrain E, Kaguelidou F, van den Anker JN. How to optimize the evaluation and use of antibiotics in neonates. Pediatr Clin North Am 2012;59:1117-28. [PMID: 23036247 DOI: 10.1016/j.pcl.2012.07.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
10 Duan P, Fisher JW, Yoshida K, Zhang L, Burckart GJ, Wang J. Physiologically Based Pharmacokinetic Prediction of Linezolid and Emtricitabine in Neonates and Infants. Clin Pharmacokinet 2017;56:383-94. [PMID: 27596256 DOI: 10.1007/s40262-016-0445-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
11 Zhou C, Zhang X, Huang X, Guo X, Cai Q, Zhu S. Rapid detection of chloramphenicol residues in aquatic products using colloidal gold immunochromatographic assay. Sensors (Basel) 2014;14:21872-88. [PMID: 25412221 DOI: 10.3390/s141121872] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
12 Allegaert K. Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology. World J Clin Pediatr 2012; 1(2): 3-7 [PMID: 25254160 DOI: 10.5409/wjcp.v1.i2.3] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]